FARAPULSE™

Pulsed Field Ablation System*

Pulsed Field Ablation: A New Era in Cardiac Ablation

Pulsed Field Ablation (PFA) is a non-thermal energy source that has the potential to transform the cardiac ablation landscape. In this five-part micro-documentary series, four European physicians share their experiences with FARAPULSE™ Pulsed Field Ablation and the FARAWAVE™ catheter. Through their insights, viewers will discover how PFA can positively impact clinical practice and enhance the atrial fibrillation (AF) ablation experience for patients.

Episode 1: Pioneering Tissue Selective Ablation

Interested in learning why cell selective energy delivery matters? In this episode Julian Chun, MD delves into the science behind irreversible electroporation and explains how FARAPULSE™ PFA energy delivery targets the cardiomyocyte, sparing the esophageal and endothelial cells. This cell selective energy delivery reduces typical thermal complications, making PFA a promising new chapter in EP.

Episode 2: Predictable Workflow

What about FARAPULSE™, and more specifically the FARAWAVE™ PFA catheter, leads to a highly predictable workflow and durable pulmonary vein isolation? Boris Schmidt, MD discusses how the purpose-built FARAWAVE catheter with an over-the-wire design is translating to rapid, reproducible, and predictable procedure times with a short operator learning curve.

Episode 3: Clinical Practice Impact

How does the FARAPULSE cell selective energy delivery with an optimized workflow and purpose-built catheter translate to clinical practice? Yuri Blaauw, MD discusses how FARAPULSE has changed his clinical practice and hospital workflow. The predictable procedure times with FARAPULSE™ PFA have allowed for treatment of more patients per day. Learn from him how this has also impacted his hospital capacity.

Episode 4: Patient Benefits

How has FARAPULSE transformed the ablation patient experience? Mattias Duytschaever, MD discusses the importance of patient safety and comfort when undergoing an AF ablation procedure. Since FARAPULSE energy is cell-selective, it limits the inflammatory response making it well-tolerated by patients who often report minimal to no chest discomfort following the procedure. Additionally, hear how FARAPULSE has provided peace of mind for both the physician and the patient in being able to offer an ablation technology with no reported rare catastrophic injuries associated with thermal ablation.

Episode 5: Promising Future

With the platform versatility and ability to create non-thermal irreversible lesions, what does the future hold for FARAPULSE™ PFA? The series concludes with the physicians discussing the importance of randomized clinical trials and large real-world registries to make informed decisions on therapy choice. Additionally, the benefits of early rhythm control to limit atrial fibrillation progression and the possibility of new patient populations being treated with what might be, the optimal energy source for cardiac ablation.

Stay up to date

FARAPULSE™: Transforming Electrophysiology and the Ablation Patient Experience

FARAPULSE Pulsed Field Ablation is an exciting development in the field of cardiac ablation, offering several benefits over traditional thermal energy sources. This micro-documentary series provides valuable insights into the clinical use of FARAPULSE™ PFA and the FARAWAVE™ catheter, demonstrating how they may positively impact patient outcomes and clinical practice.

Participating Physicians

KR Julian Chun, MD
Cardiovascular Center Bethanien (CCB)
Frankfurt, Germany

Boris Schmidt, MD
Cardiovascular Center Bethanien (CCB)
Frankfurt, Germany

Yuri Blaauw, MD
University Medical Center Groningen (UMCG)
Groningen, The Netherlands

Mattias Duytschaever, MD
St. Jan Hospital
Brugge-Oostende, Belgium

Product overview

Clinical perspectives

Videos for physicians

FARAPULSE Pulsed Field Ablation System Indications, Safety and Warnings

Top